Key Aspects of Medical Practice in Patients With Haemophilia A
NCT02996942 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-12-21
Summary
The KAPPa project has the aim to create an international database in which information about clinical features, therapeutic management, burden of illness and costs of severe and moderate haemophilia A patients from different countries and sites is collected. The aim of this project is to analyse the influence of such different characteristics on medical, psychosocial and economic outcomes in patients over the long-term.
Conditions
- Joint Disease
Interventions
- BIOLOGICAL
-
Factor VIII replacement
Patients receive their usual treatment
Sponsors & Collaborators
-
Lund University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
NCT00995046 ·Status: TERMINATED ·Phase: NA
-
Platelet Function in Patients With Hemophilia A
NCT02093065 ·Status: COMPLETED
-
German Pediatric Hemophilia Research Database
NCT02912143 ·Status: RECRUITING
-
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
NCT00782470 ·Status: COMPLETED
-
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
NCT02697370 ·Status: COMPLETED ·Phase: PHASE4
-
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells
NCT04805021 ·Status: RECRUITING
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Turkish Acquired Haemophilia Registry
NCT01403740 ·Status: UNKNOWN
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURE
NCT06212505 ·Status: COMPLETED
-
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862 ·Status: COMPLETED
-
Patterns of Hemophilia Care in Assiut Children Patients
NCT05980377 ·Status: UNKNOWN
-
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
NCT01580293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
NCT00927667 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
NCT01856751 ·Status: UNKNOWN
-
Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A
NCT02280265 ·Status: UNKNOWN ·Phase: NA
-
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
NCT04106323 ·Status: UNKNOWN
-
Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A
NCT01405742 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients
NCT01817868 ·Status: COMPLETED
-
Treatment of Hemophilia A Patients With FVIII Inhibitors
NCT04023019 ·Status: RECRUITING
-
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027 ·Status: COMPLETED
-
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care
NCT02049099 ·Status: COMPLETED
-
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
NCT02225483 ·Status: COMPLETED